准甲基基酸脱酶2 (MTHFD2) 中的全结位,通过基于结构的计算方法来识别天然产物抑制剂
Nisarg Rana1, Dhaval Patel2, Meet Parmar2
1Department of Chemistry, School of Energy Technology, Pandit Deendayal Energy University, Gandhinagar, 382426, India.
Scientific reports
|October 23, 2023
概括
研究人员发现了针对MTHFD2酶的新型化合物.
科学领域:
- 生物化学 生物化学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 乳腺癌是全球女性的主要死亡原因.
- 甲基酸酸脱酶2 (MTHFD2) 在乳腺癌中过度表达,并呈现出一种可用药物的标.
- 位向提供了一种克服药物耐药性的策略.
研究的目的:
- 为了确定针对MTHFD2.2的全位的潜在抑制剂.
- 探索天然产品作为MTHFD2抑制的候选产品.
- 研究潜在抑制剂的结合机制和稳定性.
主要方法:
- 采用了基于结构的建模和药模型.
- 进行了分子对接,HYDE评估和ADMET预测.
- 进行了分子动力学模拟,自由能量计算,MM-PBSA,PCA和FEL分析.
主要成果:
- 七个候选化合物在模拟中表现出稳定的行为.
- 六种化合物表现出与MTHFD2全囊密切结合.
- 艾洛斯特抑制降低了活性位点抑制剂的结合能,证实了艾洛斯特效应.
结论:
- 该研究确定了有希望的天然产品类化合物用于MTHFD2抑制.
- 这些化合物显示出开发新乳腺癌治疗药物的潜力.
- 准MTHFD2全位是药物开发的可行策略.
更多相关视频
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Enzyme Inhibition
78.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.5K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
The Electron Transport Chain
16.8K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.8K


